Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Hassen Kared, Andrew D. Redd, Evan M. Bloch, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 5
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 518
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 444
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Alba Grifoni, John Sidney, Randi Vita, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1076-1092
Open Access | Times Cited: 291
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients
Sunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 217
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110218-110218
Open Access | Times Cited: 180
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells
Anastasia A. Minervina, Mikhail V. Pogorelyy, Allison M. Kirk, et al.
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 781-790
Open Access | Times Cited: 169
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3962-3980.e17
Open Access | Times Cited: 131
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Yihao Liu, Qin Zeng, Caiguanxi Deng, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 122
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
Brock Kingstad-Bakke, Woojong Lee, S Chandrasekar, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 20
Open Access | Times Cited: 110
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 + T-Cell Epitopes Identified in COVID-19 Convalescent Individuals
Andrew D. Redd, Alessandra Nardin, Hassen Kared, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 82
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
Joseph J. Sabatino, Kristen Mittl, William Rowles, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 75
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.
Joshua M. Francis, Del Leistritz-Edwards, William A. Dunn, et al.
PubMed (2022) Vol. 7, Iss. 67, pp. eabk3070-eabk3070
Closed Access | Times Cited: 68
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Single-cell immunology of SARS-CoV-2 infection
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 1, pp. 30-41
Open Access | Times Cited: 100
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants
Andrew D. Redd, Alessandra Nardin, Hassen Kared, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 97
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103353-103353
Open Access | Times Cited: 80
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Antonio Bertoletti, Anthony T. Tan, Nina Le Bert
Oxford Open Immunology (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 74
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 72
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 72
Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection
Lin Yao, Guolin Wang, Yuan Shen, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 4, pp. 586-594
Open Access | Times Cited: 70
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti, Gabriele Antonarelli, Florian Scotté, et al.
Annals of Oncology (2021) Vol. 33, Iss. 2, pp. 158-168
Open Access | Times Cited: 70
Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses
Jacob K. Files, Sanghita Sarkar, Timothy Fram, et al.
JCI Insight (2021)
Open Access | Times Cited: 62
One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
Jie Zhang, Hao Lin, Beiwei Ye, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1072-e1081
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top